D J Laxman1, J S Greenberg2, L S DaWalt2, J Hong2, M G Aman3, M Mailick2. 1. Department of Human Development and Family Studies, Utah State University, Logan, UT, USA. 2. Waisman Center, University of Wisconsin-Madison, Madison, WI, USA. 3. The Nisonger Center, The Ohio State University, Columbus, OH, USA.
Abstract
BACKGROUND: The behavioural challenges and medical conditions associated with fragile X syndrome (FXS) can lead to increased need for medications. METHOD: This longitudinal study examined the use of prescription medications for psychotropic and non-psychotropic purposes by adolescents and adults with FXS drawn from a North American community sample (N = 105). Odds and probabilities of continuing or discontinuing medication were calculated. Predictors of medication use were calculated. RESULTS: More than two-thirds took psychotropic medication, and about one-quarter took non-psychotropic medication. Over a 3-year period, those who initially took prescription medications were considerably more likely to remain on medications than to stop. Individuals with more autism symptoms, more behavioural problems, a mental health diagnosis, and greater family income were significantly more likely to use psychotropic medication 3 years later. Individuals who had more health problems, a mental health diagnosis, and were female were more likely to use non-psychotropic medication over this time period. CONCLUSIONS: Findings highlight the elevated and ongoing use of medication by individuals with FXS. Implications for social and behavioural research on FXS are discussed.
BACKGROUND: The behavioural challenges and medical conditions associated with fragile X syndrome (FXS) can lead to increased need for medications. METHOD: This longitudinal study examined the use of prescription medications for psychotropic and non-psychotropic purposes by adolescents and adults with FXS drawn from a North American community sample (N = 105). Odds and probabilities of continuing or discontinuing medication were calculated. Predictors of medication use were calculated. RESULTS: More than two-thirds took psychotropic medication, and about one-quarter took non-psychotropic medication. Over a 3-year period, those who initially took prescription medications were considerably more likely to remain on medications than to stop. Individuals with more autism symptoms, more behavioural problems, a mental health diagnosis, and greater family income were significantly more likely to use psychotropic medication 3 years later. Individuals who had more health problems, a mental health diagnosis, and were female were more likely to use non-psychotropic medication over this time period. CONCLUSIONS: Findings highlight the elevated and ongoing use of medication by individuals with FXS. Implications for social and behavioural research on FXS are discussed.
Authors: Donald B Bailey; Melissa Raspa; Ellen Bishop; Murrey Olmsted; Usha G Mallya; Elizabeth Berry-Kravis Journal: J Dev Behav Pediatr Date: 2012-01 Impact factor: 2.225
Authors: Ryne Paulose-Ram; Marc A Safran; Bruce S Jonas; Qiuping Gu; Denise Orwig Journal: Pharmacoepidemiol Drug Saf Date: 2007-05 Impact factor: 2.890
Authors: Jordan Ezell; Abigail Hogan; Amanda Fairchild; Kimberly Hills; Jessica Klusek; Leonard Abbeduto; Jane Roberts Journal: J Autism Dev Disord Date: 2019-03